We are a biotechnology company offering end-to-end solutions in molecular diagnostic for oncology and hematology by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with its proprietary software embedded throughout entire workflow, EntroGen solutions are designed to be accurate, economic and scalable. EntroGen sells CRCdx®, a U.S. FDA-approved product.
Looking for a particular EntroGen, Inc. employee's phone or email?
The EntroGen, Inc. annual revenue was $5.7 million in 2026.
Matthew Minkovsky is the CEO and Founder of EntroGen, Inc..
24 people are employed at EntroGen, Inc..
EntroGen, Inc. is based in Woodland Hills, California.
The NAICS codes for EntroGen, Inc. are [54171, 541711, 5417, 54, 541].
The SIC codes for EntroGen, Inc. are [80, 28, 283].